FP7H2020HORIZON
Paracelsus Medizinische Privatuniversitat Salzburg - Privatstiftung
- Country
- ATAustria
- Defence projects
- 0
- Projects, all programmes
- 22
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 9,280,268
- Active
- 2009 to 2023
Projects
22 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MyoTreatMyopia - from genes and environment to cellular responses and treatment | HORIZON | 2023 | Participant | EUR 270,331 |
| EURASEUropean network for neurodevelopmental RASopathies | HORIZON | 2023 | Participant | EUR 1,102,938 |
| PROTOPROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES | HORIZON | 2023 | Participant | EUR 1,056,415 |
| RESONATEBuilding individual and community RESilience thrOugh NATurE-based therapies | HORIZON | 2023 | Participant | EUR 404,316 |
| NEXGEN-PDNext Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease | HORIZON | 2023 | Participant | EUR 600,000 |
| HEALHLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart | HORIZON | 2022 | Participant | EUR 259,963 |
| PD_PalPalliative care in Parkinson’s disease | H2020 | 2019 | Participant | EUR 450,000 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 163,358 |
| MUSICMultisystem Cell Therapy for Improvement of Urinary Continence | H2020 | 2017 | Participant | EUR 187,500 |
| PACEA multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | H2020 | 2017 | Participant | EUR 687,250 |
| TECHNOBEATTools and TECHNOlogies for Breakthrough in hEArt Therapies | H2020 | 2016 | Participant | EUR 644,875 |
| KNEEMOPrevention and personalized treatments in knee osteoarthritis: an Initial Training Network | H2020 | 2014 | Participant | EUR 452,082 |
| LENALabeling of Enalapril from Neonates up to Adolescents | FP7 | 2013 | Participant | EUR 336,900 |
| IDEAIdentification, homing and monitoring of therapeutic cells for regenerative medicine – Identify, Enrich, Accelerate | FP7 | 2012 | Participant | EUR 230,956 |
| INMINDImaging of Neuroinflammation in Neurodegenerative Diseases | FP7 | 2012 | Participant | EUR 449,688 |
| PRIMA-EDSPolypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in elderly populations by electronic Decision Support | FP7 | 2012 | Participant | EUR 607,505 |
| E-PREDICEEarly Prevention of Diabetes Complications in people with Hyperglycaemia in Europe | FP7 | 2012 | Participant | Not stated |
| BETA-JUDOBeta-cell function in juvenile diabetes and obesity | FP7 | 2012 | Participant | EUR 110,400 |
| NANODIARADevelopment of novel nanotechnology based diagnostic systems for Rheumatoid Arthritis and Osteoarthritis | FP7 | 2010 | Participant | EUR 392,000 |
| DISMEVALDeveloping and validating disease management evaluation methods for European health care systems | FP7 | 2009 | Participant | EUR 258,164 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.